Dipna Pharmachem P/B Ratio

Current P/B Ratio
0.51
Low Valuation
Low - Trading below book value, may indicate undervaluation

Dipna Pharmachem (DPL) P/B ratio is 0.51 (Low), book value per share ₹16.25 vs Healthcare average P/B of -0.93 — Low - Trading below book value, may indicate undervaluation. For live price, earnings yield and the full fundamental profile, see DPL share price screener.

Current Valuation Metrics

P/B Ratio 0.51
Current Price
Book Value/Share ₹16.25
Exchange None

Book Value Breakdown (2025)

Balance Sheet Components
Total Equity ₹39 Cr
Share Capital ₹24 Cr
Reserves & Surplus ₹14 Cr
Outstanding Shares 24,000,000
Book Value per Share ₹16.25

Valuation Signal

Signal Undervalued

Sector Context

Sector Average -0.93
Sector Median 0.61
Sector Rank #11 of 50
Sector Percentile 22.0%

DPL P/B Ratio — Valuation Insights & Book Value Analysis

Dipna Pharmachem price-to-book ratio interpretation, valuation status and historical context — current P/B 0.51 (Low). Compare with DPL fair value to assess whether the stock is under or overvalued.

  • Stock appears undervalued with PB of 0.51, trading below book value
  • Trading below book value - potential value opportunity or financial distress signal
  • Trading at premium to sector average PB of -0.93

DPL vs Healthcare Peers — P/B Ratio Comparison

Dipna Pharmachem P/B 0.51 vs Healthcare average -0.93, median 0.61 — range -31.21–1.04.

Sector Average
-0.93
Sector Median
0.61
Lowest P/B
-31.21
Highest P/B
1.04
Companies
50
Company Symbol P/B Ratio Market Cap (₹ Cr) Valuation
Rekvina Laboratories VINRKLB -31.21 ₹25 Low
Sun Pharma Advanced Rese… SPARC -16.05 ₹5,310 Low
Span Divergent SDL -6.32 ₹19 Low
Oxygenta Pharmaceutical OXYGENTAPH -5.54 ₹203 Low
Satiate Agri SATAGRI -3.39 ₹8 Low
Adline Chem Lab ADLINE -3.03 ₹5 Low
Bharat Immunologicals BIBCL -2.31 ₹75 Low
Parmax Pharma PARMAX -2.16 ₹12 Low
Krebs Biochemicals & Ind… KREBSBIO -0.76 ₹121 Low
Cresanto Global CRESANTO -0.7 ₹2 Low